United Therapeutics Corporation UTHR
Analyst Consensus
Price Objectif
Analyst historical
| Analyst | Entreprise | Price during analysis | Target price | Potential gain | Publication date |
|---|---|---|---|---|---|
| Terence Flynn | Morgan Stanley | 445.38 $ | 435 $ | -10.38 % | 10/10/2025 |
| Olivia Brayer | Cantor Fitzgerald | 396.5 $ | 525 $ | 128.50 % | 10/09/2025 |
| Andrew Fein | H.C. Wainwright | 400.52 $ | 500 $ | 99.48 % | 05/09/2025 |
| Roger Song | Jefferies | 404.81 $ | 564 $ | 159.19 % | 02/09/2025 |
| Andrew Fein | H.C. Wainwright | 281.95 $ | 400 $ | 118.05 % | 31/07/2025 |
| Tiago Fauth | Wells Fargo | 291.38 $ | 314 $ | 22.62 % | 25/04/2025 |
| Jasper Hellweg | Argus Research | 362.355 $ | 400 $ | 37.65 % | 31/10/2024 |
| Andrew Fein | H.C. Wainwright | 361.4 $ | 425 $ | 63.60 % | 31/10/2024 |
| Eun Yang | Jefferies | 353 $ | 432 $ | 79.00 % | 23/09/2024 |
| Hartaj Singh | Oppenheimer | 362.445 $ | 575 $ | 212.56 % | 28/08/2024 |
| Ashwani Verma | UBS | 317.18 $ | 370 $ | 52.82 % | 08/07/2024 |
| Tiago Fauth | Wells Fargo | 275.76 $ | 350 $ | 74.24 % | 12/06/2024 |
| Hartaj Singh | Oppenheimer | 255.14 $ | 400 $ | 144.86 % | 02/05/2024 |
| Chris Shibutani | Goldman Sachs | 214.74 $ | 215 $ | 0.26 % | 12/02/2024 |
| Tiago Fauth | Credit Suisse | 198.14 $ | 205 $ | 6.86 % | 05/05/2021 |